AlphAIalphai — Financial news for AI agents
SEC EDGARJUN 12 min read$VRSK

Hansen Bruce Edward sold $409K of VRSK

Hansen Bruce Edward sold 2,336 shares of Verisk Analytics, Inc. (VRSK) at $174.99 ($0.41M total) on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Hansen Bruce Edward
Published Jun 1, 2026, 9:39 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 1, 2026, 9:44 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$VRSK
Neutral
high confidence
Mentioned
$VRSK
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VRSKNeutralLow
01

Why it matters

The disclosure updates the record of insider ownership but does not introduce new operational or financial information about Verisk.

02

Market read

Traders may note the sale for positioning/sentiment, but it is unlikely to change valuation drivers absent other catalysts.

03

What to watch

The transaction is explicitly pre-arranged under Rule 10b5-1, reducing the likelihood it reflects new negative information.

Relevance 6/10Novelty 2/10Timing: Filed today (2026-06-01) for a director’s 10b5-1 sale executed the same day.

Background

SEC Form 4 reports insider transactions; Rule 10b5-1 plans are pre-set trading schedules intended to limit signaling risk.

Company-level read

Ticker impact

$VRSKNeutralHigh confidence
Context

Verisk Analytics director Bruce Hansen sold 2,336 shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Low likelihood of sustained price impact; any reaction is likely limited to intraday sentiment around the filing.

Evidence & confidence

The filing is a routine director sale executed under a pre-arranged 10b5-1 plan, with no accompanying earnings, guidance, or deal information.

Market effects

Sector

None—single-company insider transaction without sector-wide information.

Regional

None.

Global

None.

Counterpoint

What could challenge this read

10b5-1 sales can still be interpreted as confidence-neutral liquidity planning, so the market may overreact to the headline.

Key entities

  • issuer
    Verisk Analytics, Inc.

    Subject of the Form 4 insider sale by director Bruce Hansen.

  • insider
    Hansen Bruce Edward

    Director who sold 2,336 shares at $174.99/share under a 10b5-1 plan.

Read at source← All news

Related articles

AUG 8
$VRSKMedAI 8/10

Verisk Analytics (VRSK) Q2 2026 Earnings Call Transcript

Verisk Analytics (NASDAQ:VRSK) reported Q2 2026 revenue of $806 million, up 4.3% reported and 5.8% organic constant currency. Adjusted EBITDA was $464 million, up 7.4% on the same basis. Subscription revenue was 83% of total, and diluted adjusted EPS was $1.98. Full-year guidance was reaffirmed: revenue $3.19B to $3.24B and EPS $7.45 to $7.75.

aol.com6 min
AUG 7
$VRSKMedAI 8/10

Verisk Ordered to Move Ahead With $2.35 Billion AccuLynx Merger

A Delaware Chancery Court judge ordered Verisk Analytics to proceed with its $2.35 billion merger with AccuLynx, rejecting AccuLynx’s bid to raise the deal price over antitrust clearance concerns. The judge cited willful conduct by AccuLynx for a failed closing condition and awarded AccuLynx damages for direct costs plus interest. The deal still requires HSR Act clearance and FTC approval.

news.bloomberglaw.com4 min
JUL 29
$VRSKMedAI 8/10

[VRSK Q2 2026 Earnings Call] Verisk Q2 Organic Revenue Hits 5.8% as XactAI Users Jump 10x to 7,000, but Transactional Drag Persists — BigGo Finance

Verisk Analytics (VRSK) reported Q2 2026 revenue of $806 million, up 5.8% organic constant currency, driven by 8% subscription growth (83% of revenue). Transactional revenue fell 4.2% due to softer commercial property quotes and weaker weather demand. XactAI users rose 10x to 7,000. Full-year guidance of $3.19–$3.24B revenue and $1.79–$1.83B adj. EBITDA was reaffirmed.

finance.biggo.com7 min
JUL 29
$VRSKMed

Verisk Vaults on Releasing Q2 Results

Verisk (NASDAQ: VRSK) reported Q2 results for the quarter ended June 30, 2026. Net income fell 9.8% to $229 million, citing higher tax rate, net interest expense, and legal fees tied to litigation. The company paid a $0.50 dividend per share and launched a $200 million accelerated share repurchase, with an initial delivery of 949,190 shares at $179.10. Shares rose 9.6% to $221.87.

baystreet.ca3 min